NCT07807202Completed
Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-up
Improving HPV Immunization Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through an Innovative Community-Based Follow-Up: A Randomized Controlled Trial With a Waitlist Design
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
The goal of this trial is to learn if a community health worker (CHW) follow-up program can improve HPV vaccination coverage among adolescent girls in Mali and Côte d'Ivoire. The main questions it aims to answer are: Does the CHW follow-up program increase the number of girls who get vaccinated against HPV? Does the CHW follow-up program help girls get vaccinated sooner? Researchers will compare girls who receive proactive CHW home visits and digital follow-up reminders to girls who receive standard community outreach, to see if the CHW follow-up program works to increase HPV vaccination. Participants will: Be visited at home by a community health worker, who will check their HPV vaccination status Receive an invitation to get vaccinated, and reminders and follow-up visits if not yet vaccinated (intervention group only, until crossover) Have their vaccination status recorded through routine community health records, with no additional tests, surveys, or clinic visits required After an initial assessment period, girls in the standard-outreach group will also begin receiving the CHW follow-up program.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 17188 (actual)
- First submitted
- 30 Aug 2026
- Start date
- 8 Apr 2026
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- Arsène Brunelle Sandie
- Diseases
- Cervical cancer, Childhood cancers
- NCT number
- NCT07807202
What you commit to
- Study type: Interventional
- Participants enrolled: 17188
- From 8 Apr 2026 to the primary completion date, 1 Oct 2026
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Residence outside the defined study catchment areas
- Not identifiable or registered in the Community Health Toolkit (CHT) programmatic data system
Who the study is looking for
- Female adolescent residing within a participating Muso Health catchment area in Mali or Côte d'Ivoire
- Age-eligible for HPV vaccination under national immunization guidelines during the study period: 10 years of age in Mali; 9 to 14 years of age in Côte d'Ivoire
- Not yet age-eligible at study launch but expected to reach the nationally recommended vaccination age during the study period
Age in the registry: 9 years to 14 years · Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Madinani health district and Diape catchment area Coordinator of this site? Confirm its status | Abidjan | Côte d’Ivoire | Unknown status |
| Bankas, Yirimadio, and Bakorobabougou health areas Coordinator of this site? Confirm its status | Bamako | Mali | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.